What does patient empowerment mean for your treatment plan?

When Peter Hellings, MD, PhD talks his patients through different treatment options for CRS with nasal polyps, he stresses “patient empowerment and patient education.” So what does DUPIXENT offer his patients? Watch as the EUFOREA founder explains what DUPIXENT offers both patients and prescribers, and how it can provide “satisfaction from both sides.”1

When choosing a treatment for CRS with nasal polyps, it’s important for patients and HCPs to be partners in decision-making. As a nonsurgical treatment that offers efficacy benefits, DUPIXENT is an appealing therapeutic option for both parties.1

    1. DUPIXENT Summary of Product Characteristics, 2022.